Abrogation of Mitral Regurgitation Using the MitraClip System in High-Risk Patients Unsuitable for Surgery

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT01431222

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01431222
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Germany (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01431222. Randomized; no masking; primary purpose treatment. Start 2011-09 (registry gives no type); primary completion 2013-09 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Abrogation of Mitral Regurgitation Using the MitraClip System in High-Risk Patients Unsuitable for Surgery
Acronym
ISAR-CLIP
Condition
Mitral Regurgitation
Intervention (Device)
percutaneous treatment by implanting a Mitra Clip device
Lead sponsor
Deutsches Herzzentrum Muenchen (class: other)

Record details

Record id
cardio:ct-nct01431222
Content hash
41b1db4517d93b205a3721d1e111d44644fc3e4e28ba147ae733e4b7683f3661